Effects of difluoromethylornithine on growth inhibition and apoptosis in human cervical epithelial and cancerous cell lines

Gynecologic Oncology

Volumn 85, Issue 2, 2002, Pages 266-273

  Zou, Changping ^a   Vlastos, Anne Thérèse ^b   Yang, Li ^c   Wang, Jian ^a   Nishioka, Kenji ^d   Follen, Michele ^a,b,e  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c Laboratory Medicine   (United States)

^d UNIVERSITY OF TEXAS   (United States)

^e Department of Chemical and Nuclear Engineering   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; DNA FRAGMENT; EFLORNITHINE; ORNITHINE DECARBOXYLASE INHIBITOR;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER REGRESSION; CELL IMMORTALIZATION; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ASSAY; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; NICK END LABELING; PHASE 2 CLINICAL TRIAL; PRECANCER; PRIORITY JOURNAL; UTERINE CERVIX EPITHELIUM;

EID: 0036095174     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2002.6599     Document Type: Article

References (41)

1. Surrogate endpoint biomarkers for phase II cancer chemoprevention trials
2. The chemoprevention of cancer: Directions for the future
3. Progress in cancer chemoprevention: Perspectives on agent selection and short-term clinical intervention trials
4. Chemoprevention of cancer
5. Polyamines as targets for therapeutic intervention
6. Polyamine metabolism and its importance in neoplastic growth and as a target for chemotherapy
7. Critical role of polyamines in cancer: Basic mechanisms and clinical approaches
8. Inhibition of carcinogenesis by inhibitors of putrescine biosynthesis
9. Ornithine decarboxylase activity is critical for cell transformation
10. Polyamines prevent DFMO-mediated angiogenesis
11. Spermine prevents endonuclease activation and apoptosis in thymocytes
12. Tumor angiogenesis and polyamines: DFMO, an irreversible inhibitor of ornithine decarboxylase, inhibits B16 melanoma-induced angiogenesis in vivo and the proliferation of vascular endothelial cells in vitro
13. Inhibition of lymphocyte and tumor-induced angiogenesis by the administration of difluoromethylornithine
14. Clinical studies of polyamines and their antimetabolites
15. Implications and concepts of polyamine-nucleic acid interactions
16. Phase I dose de-escalation trial of α-difluoromethylornithine in patients with grade 3 cervical intraepithelial neoplasia
17. DNA image cytometric measurement as a surrogate end point biomarker in a phase I trial of α-difluoromethylornithine for cervical intraepithelial neoplasia
18. Differential effects of human papillomavirus type 6, 16, and 18 DNAs on immortalization and transformation of human cervical epithelial cells
19. Reconstituted basement membrane (matrigel): A useful semisolid medium for anchorage-independent growth of tumor cells
20. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
21. Growth inhibition of human cervical cancer cells with the recombinant adenovirus p53 in vitro
22. Chemoprevention of mouse colon tumors with difluoromethylornithine during and after carcinogen treatment
23. Polyamines as biomarkers of cervical intraepithelial neoplasia
24. Apoptosis in the genesis and prevention of cancer
25. Introduction to polyamines
26. Apoptosis and cancer chemotherapy
27. Phorbol ester (12-O-tetradecanoylphorbol 13-acetate) prevents ornithine decarboxylase inhibition and apoptosis and L1210 leukemic cells exposed to TGF-beta 1
28. Alpha-difluoromethylornithine inhibits N-nitrosomethylbenzylamine-induced esophageal carcinogenesis in zinc-deficient rats: Effects on esophageal cell proliferation and apoptosis
29. Rapid induction of apoptosis by deregulated uptake of polyamine analogues
30. Polyamine depletion arrests cell cycle and induces inhibitors p21 Waft/Cip1, p27 Kip1, and p53 in IEC-6 cells
31. Polyamine analogue induction of the p53-p21WAF1/CIP1-Rb pathway and G1 arrest in human melanoma cells
32. Polyamine analogue-mediated cell cycle responses in human melanoma cells involves the p53, p21, Rb regulatory pathway
33. Inhibition of polyamine synthesis induces p53 gene expression but not apoptosis
34. Altered cell cycle phase distributions in cultured human carcinoma cells partially depleted of polyamines by treatment with difluoromethylornithine
35. Role of ornithine decarboxylase in repair of gastrimucosal stress ulcers
36. Polyamines and ornithine decarboxylase during repair of duodenal mucosa after stress in rats
37. The c-myc gene regulates the polyamine pathway in DMSO-induced apoptosis
38. Anti-IgM-induced growth inhibition and apoptosis are independent of ornithine decarboxylase in Ramos cells
39. Normal G1/S transition and prolonged S phase within one cell cycle after seeding cells in the presence of an ornithine decarboxylase inhibitor
40. Impairment of DNA replication within one cell cycle after seeding cells in the presence of polyamine-biosynthesis inhibitor